The Spanish Medicines Agency asks to stop the commercialization and use of masks with graphene

The Spanish Agency for Medicines and Health Products (AEMPS) has called for the voluntary cessation of the marketing of masks with graphene that, according to the Canadian health authorities, could present health risks.

In a statement, the AEMPS explains that currently in Spain the commercialization of these type IIR surgical masks with biomass graphene from the manufacturer Shandong Shenquan New Materials Co. Ltd, China has been identified.

The Agency investigates the potential risk of inhalation of graphene particles from the use of these surgical masks and the risk that, in that case, it may pose. For this reason, and as a precautionary measure, it recommends not using surgical masks that contain these components.

This morning, the Minister of Health of Cantabria, Miguel Rodríguez, referred, when asked about these masks, to the statement that the Spanish Agency for Medicines and Health Products should issue.

On Wednesday, the Basque Health Service (Osakidetza) and the Ertzaintza decided to provisionally withdraw these masks, a decision that followed that of the Government of Castilla y León and the Infanta Sofía and Príncipe de Asturias hospitals. This afternoon, the Madrid City Council has joined this momentary suspension of the use of these masks pending the decision of the authorities.


Source link